T-cell acute lymphoblastic leukemia is an aggressive malignancy that does not respond well to chemotherapy; according to one study, it is biologically dependent on the proteolytic activity of the mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) protease [2]. The gene discussed is MALT1; the disease is T-cell acute lymphoblastic leukemia.